Paracel Explorer

Dernière publication·Octobre 2026

Neupogen Amgen

Filgrastimum ADNr — sol inj 30 mio U/0.5ml

Amgen Switzerland AG

Swissmedic51035

Dossier16142

Remboursement

QP 10%

Modifications (10)